Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -652 | -162 | 239 | -169 | 779 |
| Depreciation Amortization | 7 | 1 | 1 | 0 | 48 |
| Accounts payable and accrued liabilities | -154 | -305 | -79 | 73 | 769 |
| Other Working Capital | 180 | -34 | 111 | 75 | 719 |
| Other Operating Activity | -514 | -295 | -588 | -73 | -2,452 |
| Operating Cash Flow | $-1,133 | $-795 | $-315 | $-94 | $-137 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -3 | N/A | N/A | N/A |
| Investing Cash Flow | $-3 | $-3 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 194 | 181 | 169 | 132 | 155 |
| Debt Issued | N/A | N/A | N/A | -35 | N/A |
| Other Financing Activity | 1,329 | 1,399 | 1,459 | 0 | -100 |
| Financing Cash Flow | $1,522 | $1,580 | $1,627 | $96 | $55 |
| Beginning Cash Position | 0 | 0 | 0 | 0 | 82 |
| End Cash Position | 386 | 782 | 1,313 | 3 | 0 |
| Net Cash Flow | $386 | $781 | $1,312 | $3 | $-82 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,133 | -795 | -315 | -94 | -137 |
| Capital Expenditure | -3 | -3 | N/A | N/A | N/A |
| Free Cash Flow | -1,136 | -799 | -315 | -94 | -137 |